ArticleOncoTargets and therapy2018

RACKI induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression.

Bowen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.